Director/PDMR Shareholding

RNS Number : 2300W
Genedrive PLC
20 December 2021
 

PDMR Dealing

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has been notified of the following transaction by Matthew Fowler, a person discharging managerial responsibilities, and his wife who is a person closely associated with him.

Following the transfer outlined below, Matthew Fowler's total beneficial interest remains unchanged at 139,457 Ordinary Shares.

This notification is made in accordance with the Market Abuse Regulation. 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a. 

Name

Matthew Fowler

 

 

2. 

Reason for the notification

a. 

Position/status

PDMR, CFO

a. 

Initial notification

/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a. 

Name

genedrive plc

b. 

LEI

213800ZYODIRZ87Y4K14

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a. 

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 1.5 pence each

 

 

 

GB00B1VKB244

b. 

Nature of the transaction

Transfer of shares to Alison Fowler (spouse) for nil consideration.

c. 

Price(s) and volume(s)

 

 

Price £nil

 

Volume(s) 50,000 

 

 

 

 

d. 

Aggregated information

· Aggregated volume

· Price

 

 

50,000

 

Nil

 

e. 

Date of the transaction

2021-12-20

f. 

Place of the transaction

Outside a trading venue

 

For further details please contact:

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Matthew Fowler: CFO






Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel 






finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / Kate Bannatyne / Alice Lane






Walbrook PR Ltd (Media Relations & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001





 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADAEAEKFFFA

Companies

Genedrive (GDR)
UK 100

Latest directors dealings